简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Stock Yards 银行和信托公司购买LHC集团公司(纳斯达克股票代码:LHCG)的37,275股股票

2023-01-22 01:21

Stock Yards Bank & Trust Co. grew its position in shares of LHC Group, Inc. (NASDAQ:LHCG – Get Rating) by 283.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 50,422 shares of the health services provider's stock after buying an additional 37,275 shares during the period. Stock Yards Bank & Trust Co.'s holdings in LHC Group were worth $8,252,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Brown Brothers Harriman & Co. increased its position in LHC Group by 84.6% during the 2nd quarter. Brown Brothers Harriman & Co. now owns 216 shares of the health services provider's stock worth $34,000 after buying an additional 99 shares during the period. American National Bank bought a new position in LHC Group during the 3rd quarter worth $42,000. Quadrant Capital Group LLC increased its position in LHC Group by 48.3% during the 2nd quarter. Quadrant Capital Group LLC now owns 304 shares of the health services provider's stock worth $47,000 after buying an additional 99 shares during the period. Wipfli Financial Advisors LLC bought a new position in shares of LHC Group in the third quarter worth $90,000. Finally, Private Advisor Group LLC acquired a new position in LHC Group in the first quarter valued at about $225,000. Institutional investors own 83.47% of the company's stock.

Get LHC Group alerts:

LHC Group Stock Up 0.2 %

LHCG stock opened at $164.60 on Friday. The company has a quick ratio of 1.45, a current ratio of 1.45 and a debt-to-equity ratio of 0.44. The company has a market cap of $5.11 billion, a PE ratio of 80.29, a price-to-earnings-growth ratio of 21.81 and a beta of 0.44. LHC Group, Inc. has a 52 week low of $112.25 and a 52 week high of $169.84. The business has a 50-day simple moving average of $163.99 and a 200 day simple moving average of $163.60.

LHC Group (NASDAQ:LHCG – Get Rating) last issued its earnings results on Wednesday, November 2nd. The health services provider reported $1.06 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.31). The business had revenue of $576.91 million for the quarter, compared to analyst estimates of $616.65 million. LHC Group had a return on equity of 8.13% and a net margin of 2.73%. Sell-side analysts anticipate that LHC Group, Inc. will post 4.32 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on LHC Group in a research note on Wednesday, October 12th. They issued a "hold" rating for the company. Nine research analysts have rated the stock with a hold rating, According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $172.50.

LHC Group Profile

(Get Rating)

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).

Read More

  • Get a free copy of the StockNews.com research report on LHC Group (LHCG)
  • MarketBeat Week in Review – 1/16 – 1/20
  • Does Old Dominion Show That Trucking Is Hitting The Brakes?
  • Nordstrom Puts Fear Of Markdowns Into Retail Sector
  • Exxon Mobil Stock: Within Striking Distance Of Buy Point
  • High-Dividend-Yielding BHP Sees China Driving '23 Growth

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG – Get Rating).

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。